Ekso Bionics Teams Up with Performance Contracting, Inc. for Innovative Testing Approach of EVO™ Technology

Ekso Bionics Holdings today announced that Performance Contracting, Inc. (“PCI”), a leading U.S. specialty contractor, is the latest company in the construction vertical to implement field testing of EVO™ exoskeleton vests.

Over the course of a year, PCI employees in six Bay Area counties have committed to testing EVO™ exoskeleton vests for the Company’s continued product development and innovation.

“We are excited that PCI’s workforce will benefit from our novel EVO technology,” commented Michael Pratt, Vice President of Ekso Bionics. “Companies within the construction vertical are starting to recognize that EVO provides meaningful support for workers when performing routine and labor-intensive tasks. We look forward to supporting our growing user base, including PCI, with our unique solution and driving increased adoption with our flexible subscription-based offering.”

EVO is the world’s most durable, naturally-tracking, and assistive exoskeleton vest. The exoskeleton offers unique benefits in the construction industry that aids workers when performing strenuous tasks in order to reduce fatigue and worker-related injuries while increasing productivity.

“Putting our people first has always been a key differentiator at PCI,” said David Link, Regional Manager, Bay Area of PCI. “With our team of over 6,300 skilled craft workers across the United States, it is imperative for us to invest in both their well-being and productivity to remain an industry leader. Ekso’s EVO aligns with our most important core value of safety and supports our performance-driven culture. We are eager to explore this technology in the field with the goal of helping our employees achieve their fullest potential.”

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides our readership with breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

More News!

The ArthroFree system is the first FDA-cleared wireless camera for arthroscopy and general endoscopy, both areas of minimally invasive surgery. The system is designed to help surgeons work with aximum dexterity and focus.
The project, which was led by the University of Southern California, included large increases in representation among men of African, Hispanic and Asian ancestries, that were contributed in part by an ongoing collaboration between the U.S. Department of Veterans Affairs and DOE reports Argonne.
This innovative software turns smartphones into medical-grade stethoscopes, allowing people to capture, analyze, and share critical heart health data with medical personnel from the comfort of any location notes Sparrow BioAcoustics.
"Taewoong Medical becoming an Olympus group company is also a major milestone in our global growth strategy," said Henry Shin, CEO of STARmed. "We look forward to our products being made available to more patients through Olympus' global distribution network."
The company reports they have successfully met the six-month primary endpoint for the first-ever female patient implanted with the UroActive™ System, the first smart automated artificial urinary sphincter (AUS) to treat SUI.

By using this website you agree to accept Medical Device News Magazine Privacy Policy